Enanta Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Enanta Pharmaceuticals

06/05/2024 22:22

* Enanta Pharmaceuticals Inc  ENTA.OQ  reported a quarterly
adjusted loss of $1.47​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of $-1.79.  The mean expectation of seven analysts
for the quarter was for a loss of $1.33 per share. Wall Street
expected results to range from $-1.63 to $-1.11 per share.
    * Revenue fell 4.2% to $17.05 million from a year ago;
analysts
expected $16.52 million. 
    * Enanta Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.47​.
    * The company reported a quarterly loss of $31.16 million.
    * Enanta Pharmaceuticals Inc shares had fallen by 13.1% this
quarter and gained 61.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "hold."

Wall Street's median 12-month price target for Enanta
Pharmaceuticals Inc is $23.00 
This summary was machine generated from LSEG data May 6 at 09:22
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.33          -1.47          Missed
 Dec. 31 2023      -1.19          -1.58          Missed
 Sep. 30 2023      -2.15          -1.33          Beat
 Jun. 30 2023      -2.34          -1.86          Beat